Dr. Flaim holds a doctorate in Human Physiology and Pharmacology from the University of California at Davis. He held faculty positions in Medicine & Physiology at the Pennsylvania State University College of Medicine and senior management roles at the Johnson & Johnson Pharmaceutical Research Institute, the Squibb Institute for Medical Research, Alliance Pharmaceutical Corporation, Trega Biosciences, Inc., Galileo Pharmaceuticals, Inc., OncoFluor, Inc., CardioCreate, Inc. and Leading Biosciences, Inc. Dr. Flaim is a Fellow of the American College of Cardiology, the American Heart Association, the American College of Clinical Pharmacology & the Royal Society of Medicine. Dr. Flaim is Chair Emeritus of the Board of Governors for the Tech Coast Angels, Past President & Chair Emeritus of the San Diego Network of Tech Coast Angels & Emeritus Director of the Angel Capital Association. He is a member of the Editorial Board of the Journal of Pharmacology & Experimental Therapeutics, founding member of the Board of Directors & CEO for the John G. Watson Foundation, Inc. & is active in numerous regional & national scientific organizations. He is a founding member anc Technology & Business advisor to the Institute for the Global Entrepreneur at the University of California, San Diego. He is Senior Special Advisor & Investor-in-Residence to the Office of Innovation & Commercialization in the Division of Extramural Research Activities at the National Heart, Lung & Blood Institute of the National Institutes of Health. He is also an Entrepreneur-in-Residence with the Small Business Education & Entrepreneurial Development (SEED) Office in the Office of the Director of the National Institutes of Health.